Skip to content
10-Q

Quarterly Report

GREENWICH LIFESCIENCES, INC. GLSI

0001493152-24-020710

← back to feed
Filed
May 20, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 8, 2024 12.88M sh
Cash And Equivalents Q1 2024 · Mar 31, 2024 $5.51M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $6.99M
Current Liabilities Q1 2024 · Mar 31, 2024 $389.61K
Current Liabilities Q1 2024 · Dec 31, 2023 $294.41K
Total Liabilities Q1 2024 · Mar 31, 2024 $389.61K
Total Liabilities Q1 2024 · Dec 31, 2023 $294.41K
Total Assets Q1 2024 · Mar 31, 2024 $5.51M
Total Assets Q1 2024 · Dec 31, 2023 $6.99M
Shares Diluted Q1 2024 · Mar 31, 2023 12.85M sh
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$1.56M
Stockholders Equity Q1 2024 · Mar 31, 2023 $11.68M
Stockholders Equity Q1 2024 · Dec 31, 2022 $13.21M
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.17
Eps Basic Q1 2024 · Mar 31, 2023 −$0.17
Sga Expense Q1 2024 · Mar 31, 2023 $413.18K
Rd Expense Q1 2024 · Mar 31, 2023 $1.83M
Net Income Q1 2024 · Mar 31, 2023 −$2.12M
Operating Income Q1 2024 · Mar 31, 2023 −$2.24M